Literature DB >> 8299785

Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis.

S E Rier1, A K Parsons, J L Becker.   

Abstract

OBJECTIVES: To investigate the ability of peritoneal leukocytes to produce interleukin-6 (IL-6) in vitro and to determine whether IL-6 is present in the peritoneal fluid (PF) in vivo.
DESIGN: Peritoneal leukocytes were assessed for spontaneous versus stimulated IL-6 production. Interleukin-6 in the PF was also quantitated.
SETTING: Leukocytes were recovered from PF obtained at the time of diagnostic laparoscopy for pain and infertility or from women undergoing bilateral tubal ligation. PATIENTS: The study population included a total of 24 women. Experimental groups consisted of women undergoing tubal ligations (n = 6), patients with postinflammatory pelvic adhesions unrelated to endometriosis (n = 6), and women with minimal to mild endometriosis (n = 6), or moderate to severe disease (n = 6).
RESULTS: Peritoneal leukocytes from normal control women and patients with severe endometriosis spontaneously produced low levels of IL-6. In contrast, cells from women with mild disease or adhesions spontaneously released twofold to fourfold higher levels of this cytokine. Peritoneal leukocytes from patients with both mild and severe endometriosis were refractory to additional cytokine release directly in response to stimulation with endotoxin. Bioactive IL-6 was present in the PF of all patient groups, whereas immunoreactive IL-6 was not detected in this fluid.
CONCLUSIONS: These data demonstrate that IL-6 was present in the PF of all patient groups. However, the ability of peritoneal leukocytes to produce IL-6 in vitro differed according to stage of disease. We hypothesize that altered leukocyte IL-6 production in vivo may contribute to the pathophysiology of endometriosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8299785     DOI: 10.1016/s0015-0282(16)56520-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.

Authors:  J McLaren; A Prentice; D S Charnock-Jones; S A Millican; K H Müller; A M Sharkey; S K Smith
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

2.  Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis.

Authors:  Nicoletta Filigheddu; Ilaria Gregnanin; Paolo E Porporato; Daniela Surico; Beatrice Perego; Licia Galli; Claudia Patrignani; Andrea Graziani; Nicola Surico
Journal:  J Biomed Biotechnol       Date:  2010-03-10

3.  Laparoscopy for the treatment of unexplained infertility.

Authors:  Yoshiaki Kanda; Mario Ikeda; Masahiko Ishikawa; Hideya Sakakibara; Fumiki Hirahara
Journal:  Reprod Med Biol       Date:  2006-03-01

Review 4.  The Impact of Endometriosis across the Lifespan of Women: Foreseeable Research and Therapeutic Prospects.

Authors:  C L Hughes; W G Foster; S K Agarwal
Journal:  Biomed Res Int       Date:  2015-05-06       Impact factor: 3.411

5.  Immunoresponsiveness in endometriosis: implications of estrogenic toxicants.

Authors:  S E Rier; D C Martin; R E Bowman; J L Becker
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

6.  Laser capture microdissection and cDNA array analysis of endometrium identify CCL16 and CCL21 as epithelial-derived inflammatory mediators associated with endometriosis.

Authors:  Ashwini L Chand; Andrew S Murray; Rebecca L Jones; Natalie J Hannan; Lois A Salamonsen; Luk Rombauts
Journal:  Reprod Biol Endocrinol       Date:  2007-05-17       Impact factor: 5.211

7.  Resveratrol treatment reduces expression of MCP-1, IL-6, IL-8 and RANTES in endometriotic stromal cells.

Authors:  Roya Kolahdouz-Mohammadi; Farzad Shidfar; Sepideh Khodaverdi; Tahereh Arablou; Sahel Heidari; Nesa Rashidi; Ali-Akbar Delbandi
Journal:  J Cell Mol Med       Date:  2020-12-15       Impact factor: 5.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.